TORONTO, Nov. 27 /PRNewswire-FirstCall/ - Xenos Group Inc. (TSX: XNS - News) announced today the release of Xenos d2e Vision(TM) v3.0 for transforming print documents into electronic formats. Designed for rapid and seamless integration with e-Business applications, version 3.0 includes a new PCL parser supporting the PCL 6/XL format, an enhanced PDF/A generator and numerous new features and performance-increasing enhancements.
Xenos continues to innovate with new and enhanced capabilities in Xenos d2e Vision, written 100% in Java, to meet the business and technical requirements of our industry-leading customers and partners.
New Features in Xenos d2e Vision Version 3.0 include: - New PCL Parser: Transforms PCL printed output for desktop orproduction printers to other viewing and print formats. SupportsPCL6/XL. - Enhanced Barcode Support in AFP Parser: Enhanced barcode capabilitiesto existing support added to AFP Parser in version 2.1 for all themajor barcode (BCOCA) formats including 2D-Matrix. - PDF/A Font Subsetting: The PDF/A generator, released in September2006, has been enhanced to support the subsetting of embedded fontsto minimize storage requirements for long-term archiving. Subsettingreduces the file size of the generated PDF/A file by only includingthe characters of a font that are actually used in the document. - PDF Generator Fonts: Further enhanced Font Mapping capabilities toenable dynamic inter-character adjustment, further increasing thefidelity of generated PDF documents. - Double-Byte Character Support: Further enhanced existing industry-leading double-byte character support with support for Japanesedouble-byte raster character sets and Chinese character sets withinPCL documents for transformation. - AFP Generator Enhancements: Anamorphic images support added for AFPIOCA objects. Added AFP font generation from TrueType fonts. EnhancedTLE placement and generation capabilities. Compression added for PageSegment resources generated. - Image Conversion: Added the conversion of grayscale images in PDF tothe AFP RGB standard for AFP generation. - Performance Enhancements: Improved existing highly scalableperformance capabilities.
\"Xenos again is innovating with this announcement of support for the PCL6/XL format to enable enterprise-scale online document presentment solutions and high-volume production print environments,\" stated Jeff Williams, Director, Product Management, Xenos Group Inc. \"The addition of PCL6 support, numerous key enhancements and the performance increases we have implemented in Xenos d2e Vision v3.0 enable organizations to cost-effectively present or print business critical documents - regardless of the tools and systems used to create, archive and view them - without change to their existing applications.\"
Xenos d2e Vision provides flexible electronic content management, ECM archiving and dynamic e-business Web document presentment solutions with data extraction, document separation, transformation and repurposing capabilities. The easy-to-use graphical user interface, d2e Vision Developer Studio, enables higher productivity and faster return on investment.
About Xenos
Xenos (TSX:XNS - News) high-performance software solutions streamline enterprise information supply chains. We enable our customers to process, transform, repurpose, personalize and deliver their data and documents when they need it, where they need it and how they need it. Xenos extends the value of existing IT investments, enabling organizations to increase efficiency, agility and accountability.
By streamlining, standardizing and automating the handling of information on demand, our customers reduce costs while increasing a powerful competitive advantage - adaptability. Xenos has customers worldwide in financial services, insurance, healthcare, telecommunications, manufacturing, logistics, transportation, retail and government sectors. Xenos sells and supports its solutions directly from offices in Canada, the United States, the United Kingdom and France and through a global partner network. For more information, visit
Source: Xenos Group Inc.
本文链接： http://xenosinc.immuno-online.com/view-676079.html
